Use of estrogen compounds to increase libido in women
Disclosed is a method of increasing libido in a woman, said method comprising administering to said woman an effective amount of an estrogenic component selected from the group consisting of: substances represented by the following formula (I) in which formula R 1 , R 2 , R 3 , R 4 independently are a hydrogen atom, a hydroxyl group or an alkoxy group with 1-5 carbon atoms; each of R 5 , R 6 , R 7 is a hydroxyl group; no more than 3 of R 1 , R 2 , R 3 , R 4 are hydrogen atoms; precursors capable of liberating a substance according to the aforementioned formula when used in the present method; and mixtures of one or more of the aforementioned substances and/or precursors.
1. A method of increasing libido in a woman, comprising administering to said woman an effective amount of an estrogenic component selected from the group consisting of:
substances represented by the following formula
in which formula R 1 , R 2 , R 3 , R 4 independently are a hydrogen atom, a hydroxyl group or an alkoxy group with 1-5 carbon atoms; each of R 5 , R 6 , R 7 is a hydroxyl group; no more than 3 of R 1 , R 2 , R 3 , R 4 are hydrogen atoms;
derivatives of these substances wherein the hydrogen atom of at least one of the hydroxyl groups in said formula has been substituted by an acyl radical of a hydrocarbon carboxylic, sulfonic acid or sulfamic acid of 1-25 carbon atoms; tetrahydrofuranyl; tetrahydropyranal; or a straight or branched chain glycosydic residue containing 1-20 glycosidic units per residue; and
mixtures of one or more of the aforementioned substances and/or precursors.
2. The method according to claim 1 , wherein R 3 represents a hydroxyl group or an alkoxy group.
3. The method according to claim 1 , wherein at least 3 of the groups R 1 , R 2 , R 3 , and R 4 represent hydrogen atoms.
4. The method according to claim 1 , wherein the method comprises oral, transdermal, intranasal, rectal, pulmonary, buccal, subcutaneous, intravaginal or intra-uterine administration of the estrogenic component.
5. The method according to claim 4 , wherein the method comprises oral or intranasal administration.
6. The method according to claim 1 , wherein the estrogenic component is administered in an amount effective to achieve a blood serum concentration of at least 1 nanogram per liter.
7. The method according to claim 1 , wherein the estrogenic component is administered in an amount effective to achieve a blood serum concentration of at least 10 nanograms per liter.
8. The method according to claim 1 , wherein the estrogenic component is administered in a dosage of at least 1 μg per kg of bodyweight.
9. The method according to claim 1 , wherein the estrogenic component is administered in a dosage of at least 5 μg per kg of bodyweight.
10. The method according to claim 1 , wherein the estrogenic component is co-administered with a progestogenic component.
11. The method according to claim 1 , wherein the estrogenic component is co-administered with an androgenic component.
12. The method according to claim 1 , wherein the estrogenic component is administered orally.